CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor κB Activation

This publication has 65 references indexed in Scilit:

• Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
  Annals of the Rheumatic Diseases, 2013
• Interleukin-6 Production in CD40-Engaged Fibrocytes in Thyroid-Associated Ophthalmopathy: Involvement of Akt and NF-κB
  Investigative Ophthalmology & Visual Science, 2012
• Incidence of hyperthyroidism in Sweden
  European Journal of Endocrinology, 2011
• A single NFκB system for both canonical and non-canonical signaling
  Cell Research, 2010
• CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility
  PLOS ONE, 2010
• Crosstalk in Inflammation: The Interplay of Glucocorticoid Receptor-Based Mechanisms and Kinases and Phosphatases
  Endocrine Reviews, 2009
• Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic Network
  PLOS ONE, 2009
• CD40 and autoimmunity: The dark side of a great activator
  Seminars in Immunology, 2009
• The etiology of autoimmune thyroid disease: A story of genes and environment
  Journal of Autoimmunity, 2009
• Common variants at CD40 and other loci confer risk of rheumatoid arthritis
  Nature Genetics, 2008